Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) - Total Liabilities

Latest as of March 2026: CN¥1.03 Billion CNY ≈ $151.08 Million USD

Based on the latest financial reports, Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has total liabilities worth CN¥1.03 Billion CNY (≈ $151.08 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Beijing Sun Novo Pharmaceutical Research Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Beijing Sun Novo Pharmaceutical Research Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688621 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Beijing Sun Novo Pharmaceutical Research Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Sun Novo Pharmaceutical Research Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Opko Health Inc NASDAQ:OPK	USA	$652.19 Million
Prashkovsky TA:PRSK	Israel	ILA4.72 Billion
GL Events SA PA:GLO	France	€2.57 Billion
China West Construction Group Co Ltd SHE:002302	China	CN¥22.99 Billion
Exmar NV BR:EXM	Belgium	€354.16 Million
Zhejiang Tiantie Industry Co Ltd SHE:300587	China	CN¥3.67 Billion
Ratos AB (publ) ST:RATO-B	Sweden	Skr12.45 Billion
Kunming Chuan Jin Nuo Chemical Co Ltd SHE:300505	China	CN¥1.45 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Beijing Sun Novo Pharmaceutical Research Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688621 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Sun Novo Pharmaceutical Research Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)

The table below shows the annual total liabilities of Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.05 Billion ≈ $153.84 Million	+18.84%
2024-12-31	CN¥884.65 Million ≈ $129.45 Million	+9.79%
2023-12-31	CN¥805.76 Million ≈ $117.91 Million	+45.22%
2022-12-31	CN¥554.86 Million ≈ $81.19 Million	+17.30%
2021-12-31	CN¥473.01 Million ≈ $69.22 Million	+146.44%
2020-12-31	CN¥191.94 Million ≈ $28.09 Million	+15.10%
2019-12-31	CN¥166.76 Million ≈ $24.40 Million	+30.61%
2018-12-31	CN¥127.68 Million ≈ $18.68 Million	+66.20%
2017-12-31	CN¥76.82 Million ≈ $11.24 Million	--

About Beijing Sun Novo Pharmaceutical Research Co Ltd

SHG:688621 China Drug Manufacturers - Specialty & Generic

Market Cap

$858.79 Million

CN¥5.87 Billion CNY

Market Cap Rank

#9735 Global

#2581 in China

Share Price

CN¥52.40

Change (1 day)

+1.99%

52-Week Range

CN¥45.94 - CN¥82.41

All Time High

CN¥128.22